Status:
WITHDRAWN
Hyaluronic Acid Gels for Lower Lid Retraction
Lead Sponsor:
University of California, Los Angeles
Conditions:
Ectropion
Eligibility:
All Genders
21-65 years
Phase:
PHASE4
Brief Summary
Lid retraction is a difficult problem encountered in oculofacial plastic surgery. It can result from previous surgery, radiotherapy or cicatrizing disease or it may be idiopathic. Whatever the aetiolo...
Eligibility Criteria
Inclusion
- Lower eyelid retraction of \>1mm in one or both eyes.
- Complaints of either significant ocular symptoms (OSDI\>13) or cosmetic deformity associated with the eyelid retraction.
Exclusion
- Age less than 21 years: due to lack of data on safety for HAG fillers in pediatric population
- Age over 65 years of age: as HAG filler effect may be different in this population
- Are pregnant or nursing: as there is little safety data on potential teratogenicity of HAG fillers
- Have a demonstrated allergy to HAG fillers or lidocaine
- Have a current infection, skin sore, pimple, rash, hive or cyst over the injection site: to avoid worsening the infection or transmitting it
- Have a bleeding disorder or currently taking blood-thinning medications such as Coumadin or heparin on a daily basis.
- Currently active stage Thyroid Eye Disease
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01838252
Start Date
February 1 2013
End Date
May 1 2014
Last Update
December 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jules Stein Eye Institute
Los Angeles, California, United States, 90095